The largest database of trusted experimental protocols

αcd3 cd2 cd28 t cell activation beads

Manufactured by Miltenyi Biotec

The αCD3/CD2/CD28 T cell activation beads are a tool for the polyclonal activation of primary human T cells. The beads are coated with antibodies against the CD3, CD2, and CD28 molecules on the T cell surface, which can stimulate T cell proliferation and cytokine production.

Automatically generated - may contain errors

2 protocols using αcd3 cd2 cd28 t cell activation beads

1

Memory T Cell-Epithelial Interaction Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary human keratinocytes and fibroblasts were cultured to confluence in 96-well flat-bottomed plates. T cells from the three sorted memory subtypes were stimulated with αCD3/CD2/CD28 T cell activation beads (Miltenyi Biotec, San Diego, CA) at a 1:10 ratio for 24 hr. Stimulated memory T cells from each subtype were added to designated wells of confluent layers of keratinocytes, fibroblasts, or tissue culture wells without keratinocytes or fibroblasts (plastic) in Iscove’s Modified Dulbecco’s Medium supplemented with 10% FBS and L-glutamine. At indicated time points, T cells were collected and immunostained with directly conjugated anti-human monoclonal antibodies from BioLegend and Life Technologies. Acquisition of flow cytometry samples was performed on a FACS Canto instrument and data were analyzed using FACS Diva software V8.0 (BD Biosciences).
+ Open protocol
+ Expand
2

Modulation of T Cell Activation by Rapamycin

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary human keratinocytes were cultured to confluence in 96-well flat-bottomed plates. PBMC were stimulated with αCD3/CD2/CD28 T cell activation beads (Miltenyi Biotec, San Diego, CA) at a 1:10 bead:T cell ratio for 24 hours. PBMC were added to wells of keratinocytes in Iscove’s Modified Dulbecco’s Medium supplemented with 10% FBS and L-glutamine (control medium) or in control medium plus rapamycin (Selleck Chemicals, Houston, TX) at indicated concentrations. Some wells cultures were started in control medium and switched to rapamycin containing medium on day 4 or 8. Cultures were fed with control or rapamycin containing medium every other day for 7 or 14 days. At the end of the culture period, T cells were collected and stained with directly conjugated anti-human monoclonal antibodies from BioLegend and Life Technologies.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!